The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Oral lipid-based drug delivery systems – an overview
Open accessAbstract
The formulation of drugs is carried out with the principle objective of enhancing their bioavailability. Poorly water soluble drugs are challenging for the formulation scientists with regard to solubility and bioavailability. Lipid-based drug delivery systems (LBDDS) are one of the emerging technologies designed to address such challenges. Encapsulating or solubilizing the drug in lipid excipients can lead to increased solubilization and absorption, resulting in enhanced bioavailability. Recent advances in these formulation technologies have led to the successful commercialization of lipid-based formulations. This review provides a comprehensive summary and characterization of lipid-based formulations, especially for oral delivery, from both physicochemical and biopharmaceutical perspectives. This review also focuses on the processing techniques necessary to obtain solid lipid-based formulations for oral delivery, along with a brief discussion of lipid excipients and their characterization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Handbook of Pharmaceutical Excipients
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (1994) · Cited by 3,493
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Kararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Pouton, C. W. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.016 · Cited by 1,293
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230
Pouton, C. W., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.010 · Cited by 885
Formulation of self-emulsifying drug delivery systems
Pouton, C. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00490-5 · Cited by 624
Charman, W. N., Porter, C. J. H., Mithani, S., & Dressman, J. B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960085v · Cited by 617
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A. J., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 577
Sethia, S., & Squillante, E. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.025 · Cited by 442
In vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389
Approaches for the development of solid and semi-solid lipid-based formulations
Jannin, V., Musakhanian, J., & Marchaud, D. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.006 · Cited by 388
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Dahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Hauss, D. J., Fogal, S. E., Ficorilli, J. V., Price, C. A., Roy, T., Jayaraj, A. A., & Keirns, J. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970300n · Cited by 316
Influence of food and diet on gastrointestinal drug absorption: A review
Welling, P. G. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061694 · Cited by 307
A relation between the chain length of fatty acids and the slowing of gastric emptying
Hunt, J. N., & Knox, M. T. (1968) · The Journal of Physiology · doi:10.1113/jphysiol.1968.sp008411 · Cited by 301
Aungst, B. J. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600821008 · Cited by 294
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00169-5 · Cited by 287
Collnot, E.-M., Baldes, C., Wempe, M. F., Kappl, R., Hüttermann, J., Hyatt, J. A., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060121r · Cited by 280
Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
Benet, L. Z., Cummins, C. L., & Wu, C. Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2002.12.002 · Cited by 256
Cole, E. T., Cadé, D., & Benameur, H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.009 · Cited by 241
Hugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., & Borchardt, R. T. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10176 · Cited by 237
Occurrence and Characteristics of Oils and Fats
Padley, F. B., Gunstone, F. D., & Harwood, J. L. (1986) · The Lipid Handbook · doi:10.1007/978-1-4899-2905-1_3 · Cited by 235
Dahan, A., & Hoffman, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.017 · Cited by 230
Chauhan, B., Shimpi, S., & Paradkar, A. R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.06.005 · Cited by 221
Nicolaides, E., Symillides, M., Dressman, J. B., & Reppas, C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011071401306 · Cited by 208
Kaukonen, A. M., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016282.77887.1f · Cited by 206
Liquid filled nanoparticles as a drug delivery tool for protein therapeutics
Venkatesan, N., Yoshimitsu, J., Ιtο, Y., Shibata, N., & Takada, K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.012 · Cited by 198
Dahan, A., & Hoffman, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9054-x · Cited by 195
A dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Gjelstrup Kristensen, H., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00182-8 · Cited by 194
(2006) · CRC Press eBooks · doi:10.1201/9781420004816 · Cited by 187
Christensen, J. Ø., Schultz, K., Mollgaard, B., Kristensen, H. G., & Mullertz, A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.08.003 · Cited by 186
Collnot, E.-M., Baldes, C., Wempe, M. F., Hyatt, J., Navarro, L., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.005 · Cited by 184
Sek, L., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(00)00528-8 · Cited by 175
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Grevel, J., Lücker, P. W., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018922517162 · Cited by 170
Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., & Yamamoto, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20017 · Cited by 165
Passerini, N., Albertini, B., Perissutti, B., & Rodriguez, L. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.028 · Cited by 162
Cuiné, J. F., Charman, W. N., Pouton, C. W., Edwards, G. A., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9194-z · Cited by 157
Khoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 150
Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
Charman, W. N., Rogge, M. C., Boddy, A. W., & Berger, B. M. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb04673.x · Cited by 141
Oral solid gentamicin preparation using emulsifier and adsorbent
Ιtο, Y., Kusawake, T., Ishida, M., Tawa, R., Shibata, N., & Takada, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.017 · Cited by 135
Uptake of drugs into the intestinal lymphatics after oral administration
Porter, C. J. H., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00492-9 · Cited by 135
Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs
(2007) · CRC Press eBooks · doi:10.3109/9781420017267 · Cited by 134
Roger, E., Lagarce, F., & Benoît, J. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.021 · Cited by 133
A physicochemical Basis for the Effect of Food on the Absolute Oral Bioavailability of Halofantrine
Humberstone, A., Porter, C. J. H., & Charman, W. N. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950472p · Cited by 132
Pancreatic colipase. Structural and physiological aspects
Erlanson‐Albertsson, C. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90147-n · Cited by 128
Intestinal drug efflux: formulation and food effects
Wagner, D., Spahn-Langguth, H., Hanafy, A., Koggel, A., & Langguth, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00183-1 · Cited by 127
Fernandez, S., Jannin, V., Rodier, J.-D., Ritter, N., Mahler, B., & Carrière, F. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.009 · Cited by 126
Prabhu, S. V., Ortega, M., & Ma, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.032 · Cited by 124
Saquinavir Soft-Gel Capsule Formulation
Perry, C. M., & Noble, S. (1998) · Drugs · doi:10.2165/00003495-199855030-00014 · Cited by 119
Animal models for the study of intestinal lymphatic drug transport
Edwards, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00148-x · Cited by 112
High-performance liquid chromatography and lipids : a practical guide
Christie, W. W. (1987) · Medical Entomology and Zoology · Cited by 104
Gill, K. K., Kaddoumi, A., & Nazzal, S. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.02.010 · Cited by 100
Gershkovich, P., & Hoffman, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.109 · Cited by 92
On the positional specificity of phospholipase A from pancreas
van den BOSCH, H., Postema, N. M., Haas, G. H. D., & Deenen, L. L. M. V. (1965) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(65)90168-2 · Cited by 91
Self-Emulsification of Vegetable Oil-Nonionic Surfactant Mixtures
Wakerly, M. G., Pouton, C. W., Meakin, B. J., & Morton, F. (1986) · ACS symposium series · doi:10.1021/bk-1986-0311.ch018 · Cited by 79
Zhang, Y., Wang, R., Wu, J., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.013 · Cited by 74
Seeballuck, F., Ashford, M. B., & O’Driscoll, C. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1024422625596 · Cited by 73
Griffin, B. T., & O’Driscoll, C. M. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.7.0006 · Cited by 71
Chen, Y., Zhang, W., Gu, J., Ren, Q., Fan, Z., Zhong, W., Fang, X., & Sha, X. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.015 · Cited by 66
Devani, M. J., Ashford, M. B., & Craig, D. Q. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022872 · Cited by 65
Martignoni, M., de Kanter, R., Grossi, P., Mahnke, A., Saturno, G., & Monshouwer, M. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.10.002 · Cited by 64
Zhao, Y., Dai, D., Lu, C., Chen, L., Lin, M. H., Shen, X.-T., Li, X., Zhang, M., Jiang, X., Jin, R., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.031 · Cited by 57
Stabilization and Improved in Vivo Performance of Amorphous Etoricoxib using Gelucire 50/13
Shimpi, S. L., Chauhan, B., Mahadik, K. R., & Paradkar, A. R. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6694-1 · Cited by 54
Petri, N., Bergman, E., Forsell, P., Hedeland, M., Bondesson, U., Knutson, L., & Lennernäs, H. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008409 · Cited by 42
Bioavailability of seocalcitol
Grove, M. F., Müllertz, A., Pedersen, G. P., & Nielsen, J. L. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.01.007 · Cited by 38
Singh, B. N. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120050250 · Cited by 21
Enhanced Gastrointestinal Absorption of Lipophilic Drugs
Hoffman, A., & Dahan, A. (2006) · CRC Press eBooks · doi:10.1201/9780849332036.ch6 · Cited by 18
Cited by
Insoluble drug delivery strategies: review of recent advances and business prospects
Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410
Self-citationRole of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Haddadzadegan, S., Dorkoosh, F., & Bernkop-Schnürch, A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114097 · Cited by 424
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., Salminen, T. A., Toivola, D., Abankwa, D., Rosling, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700258 · Cited by 315
Buya, A. B., Beloqui, A., Memvanga, P. B., & Préat, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121194 · Cited by 301
Metadata
- Authors
- Kalepu, S., Manthina, M., & Padavala, V.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 3
- Issue
- 6
- Pages
- 361-372
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2029074248
- Cited by
- 494
- References
- 72
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.